AI assistant
Lite Strategy, Inc. — Director's Dealing 2018
Aug 9, 2018
34267_dirs_2018-08-08_c0c0db25-e289-4697-978e-83040f994b2e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: MEI Pharma, Inc. (MEIP)
CIK: 0001262104
Period of Report: 2018-08-06
Reporting Person: Urso David M (Chief Operating Officer & GC)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-08-06 | Common Stock | F | 17764 | $3.75 | Disposed | 33606 | Direct |
| 2018-08-07 | Common Stock | S | 9500 | $3.5836 | Disposed | 24106 | Direct |
Footnotes
F1: Represents the number of shares withheld by and surrendered to the Issuer on August 6, 2018, to satisfy tax withholding obligations that arose in connection with the delivery of shares underlying restricted stock units that vested on August 5, 2018.
F2: Represents the number of shares sold to satisfy tax withholding obligations that arose in connection with the delivery of shares underlying restricted stock units that vested on August 5, 2018.
F3: The range of sales prices was $3.5825 to $3.60. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information will be provided regarding the number of shares purchased or sold at each separate price.